SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-002012
Filing Date
2018-02-14
Accepted
2018-02-14 07:15:38
Documents
43
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ODT-10K-20171231 odt-10k_20171231.htm 10-K 1566284
2 EX-10.1 LIMITED LIABILITY COMPANY OPERATING AGREEMENT OF ODONATE HOLDINGS, LLC odt-ex101_1520.htm EX-10.1 83869
3 EX-10.2 ODONATE THERAPEUTICS, INC. 2017 STOCK OPTION PLAN odt-ex102_1519.htm EX-10.2 89776
4 EX-10.3 FORM OF STOCK OPTION AWARD odt-ex103_1518.htm EX-10.3 54563
5 EX-10.4 ODONATE THERAPEUTICS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN odt-ex104_1517.htm EX-10.4 75821
6 EX-31.1 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 odt-ex311_1072.htm EX-31.1 17332
7 EX-31.2 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14 odt-ex312_1073.htm EX-31.2 17238
8 EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFF odt-ex321_403.htm EX-32.1 14602
9 GRAPHIC g2018021402074650486769.jpg GRAPHIC 15094
10 GRAPHIC g2018021402074619486756.jpg GRAPHIC 9336
11 GRAPHIC g2018021402074702986782.jpg GRAPHIC 19796
12 GRAPHIC g2018021402074647786765.jpg GRAPHIC 19267
13 GRAPHIC g2018021402075565286786.jpg GRAPHIC 23613
14 GRAPHIC g2018021402074660586778.jpg GRAPHIC 37031
15 GRAPHIC g2018021402074641386761.jpg GRAPHIC 37460
16 GRAPHIC g2018021402074658886777.jpg GRAPHIC 33713
17 GRAPHIC g2018021402074652786771.jpg GRAPHIC 12621
18 GRAPHIC g2018021402074653586772.jpg GRAPHIC 12321
19 GRAPHIC g2018021402074651386770.jpg GRAPHIC 27362
20 GRAPHIC g2018021402074616486753.jpg GRAPHIC 32470
21 GRAPHIC g2018021402074703686783.jpg GRAPHIC 16315
22 GRAPHIC g2018021402074646086764.jpg GRAPHIC 44564
23 GRAPHIC g2018021402074711286784.jpg GRAPHIC 20087
24 GRAPHIC g2018021402074649586768.jpg GRAPHIC 17786
25 GRAPHIC g2018021402074661186779.jpg GRAPHIC 39261
26 GRAPHIC g2018021402074618886755.jpg GRAPHIC 5641
27 GRAPHIC g2018021402074642786762.jpg GRAPHIC 22335
28 GRAPHIC g2018021402074649086767.jpg GRAPHIC 12861
29 GRAPHIC g2018021402074654386774.jpg GRAPHIC 17174
30 GRAPHIC g2018021402074624886760.jpg GRAPHIC 28111
31 GRAPHIC g2018021402074618286754.jpg GRAPHIC 13373
32 GRAPHIC g2018021402074697786780.jpg GRAPHIC 34822
33 GRAPHIC g2018021402074615486752.jpg GRAPHIC 18378
34 GRAPHIC g2018021402074700786781.jpg GRAPHIC 24920
35 GRAPHIC g2018021402074623786758.jpg GRAPHIC 13471
36 GRAPHIC g2018021402074713786785.jpg GRAPHIC 31743
37 GRAPHIC g2018021402074643886763.jpg GRAPHIC 69670
38 GRAPHIC g2018021402074657286776.jpg GRAPHIC 19696
39 GRAPHIC g2018021402074648186766.jpg GRAPHIC 27126
40 GRAPHIC g2018021402074619886757.jpg GRAPHIC 15820
41 GRAPHIC g2018021402074624186759.jpg GRAPHIC 5696
42 GRAPHIC g2018021402074655586775.jpg GRAPHIC 15264
43 GRAPHIC g2018021402074653886773.jpg GRAPHIC 12463
  Complete submission text file 0001564590-18-002012.txt   3037335
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38318 | Film No.: 18607036
SIC: 2834 Pharmaceutical Preparations